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Purpose: The study assessed the knowledge of both HIV and non-HIV hypertensive patients on 
hypertension and the role of pharmacists in their pharmaceutical care. 
Methods: The study was conducted at the hypertension and HIV clinics in government hospitals in Dar 
es Salaam, Tanzania. Patients were interviewed using a structured questionnaire and pharmacists were 
assessed using a self-administered questionnaire and by observation. 
Results: Few patients in both groups knew the names of antihypertensive medicines they were taking. 
Information on the use of antihypertensive and antiretroviral (ARV) medicines was mostly provided by 
doctors. Adverse drug reactions were significantly more when patient used both ARVs and 
antihypertensive medicines than when they used only antihypentsives. Only 20 % of hypertensive-HIV 
patients informed the pharmacist dispensing antihypertensive medicines that they were using ARVs, 
and only 19 % of the pharmacists knew the drug interactions between ARVs and antihypertensive 
medicines. During dispensing, about 2 % of the patients were asked about other medicines being used. 
Conclusion: There is a need to improve patients’ knowledge of hypertension. The pharmacists should 
also have up-to-date knowledge of hypertension-HIV co-morbidity. Proper coordination between HIV 
and hypertension clinics and the full integration of a pharmacist in the health care team can help to 
improve patient care. 
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INTRODUCTION 
 
Hypertension is one of the chronic diseases 
affecting people especially those living in 
urban areas. The prevalence of hypertension 
in the urban areas of Tanzania is about 30 % 
[1]. In the HIV-infected population, the 
prevalence of hypertension is around 13.1 % 
[2] while for those patients on highly active 
antiretroviral therapy (HAART), it is around 
21 % [3]. The use of HAART for the treatment 
of HIV infection is associated with the 
development of cardiovascular risk factors, 
including hypertension, hyperlipidemia, 
diabetes mellitus, impaired glucose tolerance, 
and visceral fat deposition [2,4]. 
  
Patients who are both HIV-positive and 
hypertensive are likely to be receiving 
multiple drug therapy as a result of medical 
complications associated with the disease 
and therefore, need intervention by a 
pharmacist. It has been observed that in 
Tanzanian public health facilities, a 
pharmacist is not an integral part of the 
health care team [5]. Consequently, patients 
are deprived of useful information regarding 
their disease, medication and quality of life 
issues. The various complications which 
result from multiple drug therapy in these 
patients have not been determined.  In 
addition, the level of involvement of the 
pharmacist in the management of these 
patients in Tanzania has not been assessed. 
 
This study, therefore, focused on assessing 
the knowledge of hypertension among two 
groups of patients: hypertensive-only and 
hypertensive-HIV patients. The involvement 
of pharmacists in the counselling of these 
patients was also assessed.  In addition, the 
study assessed problems which were 
encountered by both groups of patients in the 
course of using anti-hypertensive and ARV 
medicines alone or in combination. 
Pharmacists’ knowledge of hypertension and 
cardiovascular effects due to ARV use were 
also assessed. 
METHODS   
 
This was a cross-sectional descriptive study 
conducted at hypertension and HIV clinics at 
four government hospitals, as well as at 
community pharmacies in Dar-es-Salaam, 
Tanzania, for a period of three months from 
July to September  2007. 
 
Convenience sampling method was used. 
Two hundred (200) hypertensive-only 
patients on anti-hypertensive medicines and 
200 hypertensive-HIV patients on both ARVs 
and anti-hypertensive medicines attending 
the clinics who consented to participate in the 
study were recruited and interviewed using 
questionnaires. Children, pregnant women 
and those not using medications were 
excluded from the study. A total of 100 
pharmacists who consented to participate in 
the study were also recruited and assessed 
using a self-administered questionnaire in 
both hospital and community pharmacies. 
One hundred (100) dispensing encounters at 
the HIV clinics were observed.  
 
Ethical clearance was obtained from the 
Ethical Review Committee of Muhimbili 




Statistical Package for Social Sciences 
(SPSS), version 11.5 for Windows, was used 
for data analysis. Frequences and 
percentages were determined and Chi 





The demographic characteristics of the 
patients are shown in Table 1. A majority of 
the hypertensive-only patients were in the 
age groups 40 – 59 (46.5 %) and 60+ (47.5 
%)  while a majority of hypertensive-HIV 
patients (61 %) were middle-aged (40 – 59 
years).  The mean age for the hypertensive-
only patients was 57.8 years (range: 27 to 
102 years) and for the hypertensive-HIV 
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Table 1: Social demographic characteristics of patients 
 
 
Hypertensive-only patients Hypertensive-HIV patients Variable  
Frequency (%) Frequency  (%) 
Age group(yr)     
<40 12 6 52 26 
40-59 93 46.5 122 61 
60+ 95 47.5 26 13 
Sex     
Male 69 35.5 62 31 
Female  131 65.5 138 69 
Education level     
No formal 74 37 44 22 
Primary     98 49 116 58 
Secondary 21 10.5 36 18 
Post-secondary 7 3.5 4 2 
Occupation     
Employed  58 29 84 42 
Unemployed 142 71 116 58 
 
 
Table 2: Knowledge of patients and source of information on hypertension  
 
Hypertensive-only  Hypertensive-HIV   Knowledge 
Frequency % Frequency % 
Name of disease 
200 100 200 100 
Symptoms of hypertension 120 60 96 48 
Consequences of untreated hypertension 81 40.5 58 29 
Names of antihypertensive medicines being used 48 24 26 13 
Source of information on hypertension     
Peer 142 71 152 76 
Media 13 6.5 45 22.5 
Formal education 1 0.5 - - 
 
patients, it was 47.1 years (range: 21 to 80 
years).  The male/female ratio was low in 
each group with females being twice as many 
as males.  This finding was comparable in 
both groups.  A majority in each of the patient 
groups had primary level education; more 
than a half of the subjects in both groups 
(71% and 58%) were unemployed.  
 
Table 2 shows the results of the knowledge 
of patients about their disease conditions and 
the source of information. Only a few of the 
hypertensive patients in both groups knew 
the names of anti-hypertensive medicines 
they were using. The biggest source of 
information on hypertension was from peer 
groups.  The level of knowledge of the 
symptoms of hypertension was significantly 
higher in the hypertensive-only group (60 %) 
than the hypertensive-HIV group (48 %) (Chi 
square = 5.79; p < 0.05; df = 1).  Of the two 
groups, hypertensive-only (40.5 %) and 
hypertensive-HIV (29 %) patients were not 
aware of the consequences of uncontrolled/ 
untreated hypertension. Both groups reported 
that they were  informed about the types of 
lifestyle modification required in their present 
disease conditions. The most prevalent 
reported lifestyle changes were low  salt  
intake,  exercise, a diet rich in 
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Table 3: Involvement of health workers in counseling of hypentensive and HIV patients 
 
Person giving information (% ) 
Type of information  
Doctor Nurse Pharmacist 
Symptoms of hypertension 24.5 0.5 0 
Life style changes 62.5 5 1 
Use of ARV drugs 44.5 47.5 23 
Use of antihypertensive drugs 94 3 2.5 
Consequences of untreated 
hypertension 8.5 0.5 0.5 
Caution on side effects of ARVs  
and antihypertensive medicines 37.5 52.5 16 
 
fruits and vegetables, low alcohol and no 
smoking.  
 
As Table 3 shows, doctors were a more 
frequent source of information on 
hypertension and ARVs than pharmacist  
 
Information to the dispenser by the 
patient regarding ARV use 
 
Only 20 % of the hypertensive-HIV patients 
informed the dispenser at the hypertension 
clinic that they were using ARVs as well.  On 
the other hand, 36 % of the hypertensive-HIV 
patients informed the dispenser at the HIV 
clinic that they were using anti-hypertensive 
medicines. 
 
Adverse drug reactions (ADRs) faced by 
both patient groups  
 
The number of hypertensive-HIV patients 
who developed hypertension before HIV and 
were on anti-hypertensive medicines prior to 
being placed on ARVs was 104 (52 %) while 
those who developed hypertension after 
knowing their HIV status and were on ARVs 
prior to being placed on anti-hypertensive 
medicines were 96 (48 %).   
 
Some of the hypertensive-HIV patients (22%) 
reported that they experienced ADRs while 
using anti-hypertensive medicines alone prior 
to being placed on ARVs.  However, when 
these patients began to use ARVs in 
combination with the anti-hypertensive 
medicines, ADRs increased significantly 
(84.6 %; Chi-square = 81.833; p < 0.05; df 
=1). Likewise, a majority of the hypertensive-
HIV patients who were on ARVs alone (82.3 
%) experienced ADRs.  However, these 
ADRs were significantly higher (92.7 %) 
when they used a combination of ARVs and 
anti-hypertensive medicines (Chi-square = 
4.766; p < 0.05; df = 1). 
   
Fatigue (Chi square = 6.1523; p < 0.05; df = 
1)) and headache (Chi square = 4.246; p < 
0.05; df = 1) were more common in the 
hypertensive-HIV group than in the 
hypertensive-only group. In those patients 
who were using anti-hypertensive medicines 
prior to being placed on ARVs, fatigue and 
GIT disturbances were less frequently but 
when used in combination with ARVs, these 
ADRs were more frequent (fatigue, Chi-
square = 19.82; p < 0.05; df = 1; and GIT 
disturbances, Chi-square = 57.86; p < 0.05; 
df = 1).  However, in patients who were using 
ARVs prior to taking anti-hypertensive 
medicines, fatigue and drowsiness were less 
frequently reported but when used in 
combination with the anti-hypertensive 
medicines these ADRs were occurred more 
frequently (fatigue, Chi-square = 118.77; p < 
0.05; df =1; and drowsiness, Chi-square = 
45.59; p < 0.05; df = 1).    
 
Drowsiness (Chi-square = 6.25; p < 0.05; df = 
1), rash (Chi-square = 6.79; p < 0.05; df =1) 
and nightmares (Chi-square = 10.13; p < 
0.05; df = 1) occurred significantly more in 
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hypertensive-HIV patients who were on ARVs 
alone prior to being placed on anti-
hypertensive medicines than in those who 
were on anti-hypertensive medicines alone 
prior to being placed on ARVs.  
 
Pharmacists’ knowledge of hypertension 
and anti-hypertensive agents 
 
Table 4 presents data on pharnacists’ 
knowledge of hypentension. Only 15 % of 
pharmacists could clearly define 
hypertension. Their knowledge on different 
antihypertensive medicines is shown in Table 
4.  
 
Table 4: Knowledge of pharmacists on 
hypertension  
 
Knowledge item %  
Definition of hypertension 15 
Goals of treatment of hypertension 95 
Types of hypertension 9 
Causes of secondary hypertension 67 
Signs and symptoms of hypertension 98 
Complications of untreated hypertension 98 
Risk factors of hypertension 90 
Type of lifestyle modification  100 
Drugs which induce hypertension 73 
Types of anti-hypertensive medicines 
contraindicated in: 
 
        Diabetes 59 
        Asthma 75 
Heart failure 10 
Antihypertensive drug of choice in heart 
failure and diabetes 
13 
Drug interaction between antihyperten-
sive medicines and other medicines 
35 
HIV associated Hypertensive problems 
due to ARVs 
10 
Drug- drug interaction between the 
ARVs and anti-hypertensive medicines 
19 
 
Patient counseling  
 
Of the 100 patients observed during the drug 
dispensing process, no patient was 
counseled on drug-drug interactions while 
only 2 % were asked if they were using other 




Figure 1: Counseling of hypertensive-HIV patients 
on the use of ARVs by pharmacists (A= Name and 
description of the medication; B= Instructions on 
the use of medications; C=Frequency and duration 
of therapy; D=Food drug interaction; E=Asked 
about other medicines being used; F=Precaution 
on common side effects; G= Drug-drug 




The results obtained indicate that both 
groups of patients were not knowledgeable 
about specific factors related to hypertension 
such as symptoms of hypertension, 
consequences of uncontrolled hypertension, 
names of anti-hypertensive medicines they 
are using, and specifically their own level of 
blood pressure control. Lack of knowledge of 
hypertension can result in uncotrolled blood 
pressure. Studies have shown that about 50 
– 75 % of patients being treated for 
hypertension do not have adequate control of 
their blood pressure due to lack of knowledge 
of hypertension [6-9].  
 
The median duration of hypertension for the 
hypertensive-only group was 6 years and for 
the hypertensive-HIV group was 2 years, 
suggesting that though these patients have 
had this condition for a fair long time, their 
knowledge of the disease was inadequate. 
The level of knowledge of symptoms of 
hypertension was significantly higher in the 
hypertensive-only group and this could be 
due to the counseling being carried out in the 
hypertension clinic whereby focus is on 
hypertension only while in the HIV clinic, 
counseling emphasis is on HIV only.  Thus, 
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the hypertensive-HIV patient might tend to 
attach more importance to HIV than 
hypertension.   
 
Both groups of patients did not know the 
names and strength of the anti-hypertensive 
medicines they were using.  Thus, if they 
experienced any adverse drug reaction or 
any other problems they would not be able to 
report which drug caused it.  Moreover, they 
would not be able to inform the doctor  or 
pharmacist which medicines they were using.   
Not knowing the consequences of 
uncontrolled hypertension can lead to 
patients not adhering to their medications 
thus leading to uncontrolled hypertension, 
leading eventually stroke, end organ damage 
(such as renal failure), heart failure or 
myocardial infarction, and blindness. A 
previous study has shown that patients who 
were aware that elevated blood pressure 
levels leads to reduction in life expectancy 
had a greater compliance level with 
medication use and follow up visits than 
patients without this awareness [10]. 
 
In this study 22.1 % of the hypertensive-HIV 
and 23 % of the hypertensive-only patients 
developed at least one ADR when they were 
on anti-hypertensive medicines alone.  This 
rate is higher than the 15.3 % previously 
reported in a similar study conducted in 
Denmark [11] but similar to the one reported 
by Gholami 2008 in Tehran [12].This 
difference may be due to differences in the 
populations studied, types and number of 
drugs used by the patients, the definition 
used for ADR and susceptibility of patients to 
adverse reactions induced by anti-
hypertensive medicines.   
 
Hypertension and HIV are both chronic 
diseases and therefore, the use of medicines 
is life-long.  In this study, ADRs were 
significantly more frequent when a 
combination of ARVs and anti-hypertensive 
medicines were used than when either of 
these medicines was used.  Studies have 
shown that antihypertensive medicines, when 
used together with ARVs, tend to increase 
the side-effects of the latter [4]. 
 
The type of ADRs experienced when anti-
hypertensive medicines were used alone in 
the hypertensive-HIV patients were almost 
similar to that experienced by the 
hypertensive-only patients.  Fatigue and 
headache occurred more frequently in 
hypertensive-HIV patients than in 
hypertensive-only patients.  This could be 
due to the combined effect of the two 
medication types as both HIV and anti-
hypertensive medicines cause fatigue and 
headache. The incidence of drowsiness was 
higher after hypertensive-HIV patients were 
placed on anti-hypertensive medicines than 
when they were using ARVs alone.  
Drowsiness is often associated with the use 
of anti-hypertensive medicines. 
   
Pharmacists in Dar es Salaam were not very 
knowledgeable on HIV and hypertension. A 
majority of the pharmacists (90 %) were not 
aware of any HIV-related hypertensive 
problems.  Furthermore, a majority (81 %) of 
them also did not have any knowledge of 
interactions between ARVs and anti-
hypertensive agents. This situation is 
different from those of other countries where 
pharmacists have co-managed with doctors 
hypertensive patients well [13]. 
 
The patient’s last stop is usually the 
pharmacy where the pharmacist dispenses 
the medicines and advises patients on their 
use.   Thus, it is important that pharmacists 
have up to date knowledge so that they can 
assist in patient education, which can assist 
HIV patients to minimize problems such as 
drug-drug interactions, non-adherence to 
medications and adverse drug reactions. In 
this study, it both groups of patients that 
patient education regarding their disease 
conditions and medication was mostly 
provided by doctors and nurses.  The 
pharmacist was practically not involved in 
patient education in this regard.  This is likely 
due to the fact that in Tanzania, hypertension 
clinics usually do not engage pharmacists. In 
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this context, even if the pharmacist were to 
be engaged by the clinics, the pharmacist still 
faces certain obstacles. For instance, the 
current patient card of the HIV patients does 
not provide for the previous medication 
history of the patient. Thus, the pharmacist 
would not know whether the patient is 
hypertensive or not and what medications 
he/she is currently using.  This study has 
revealed that patients did not know the 
names of the medicines they ere taking. 
Furthermore, in the hypertensive clinic, the 
patient may not want to reveal his/her HIV 
status and hence the pharmacist is 
handicapped to counsel on side effects and 
drug interaction. Ultimately, the patient is the 
loser, in that he misses out on important 
information regarding his disease condition 




There is a need to improve the patients’ 
knowledge and awareness of hypertension 
so as to reduce the morbidity and mortality 
associated with hypertension. Proper co-
ordination between HIV and hypertension 
clinics, as is the case for HIV and TB clinics, 
should help in improving patient care.  At the 
moment, pharmacists in Tanzania are not 
fully integrated into the primary health care 
team.  Pharmacists’ skills should be tapped 
to assist patients with their long-term 
medicines use.  This also requires hat 
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